Fisher & Paykel Healthcare Corporation Limited (FRA:FPLB)

Market Cap	13.41B +21.4%
Revenue (ttm)	1.14B +14.2%
Net Income	232.18M +24.2%
EPS	0.39 +24.1%
Shares Out	n/a
PE Ratio	57.77
Forward PE	47.12
Dividend	0.30 (1.35%)
Ex-Dividend Date	Jun 22, 2026

Volume	n/a
Open	22.40
Previous Close	22.60
Day's Range	22.40 - 22.40
52-Week Range	16.00 - 22.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:FPLB

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1934
• Employees: 7,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FPLB

Financial Performance

In fiscal year 2026, FRA:FPLB's revenue was 2.31 billion, an increase of 14.22% compared to the previous year's 2.02 billion. Earnings were 468.50 million, an increase of 24.20%.

Financial numbers in NZD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error